Beta-Amyloid monomer and insulin/IGF-1 signaling in Alzheimer's disease

Maria Laura Giuffrida, Flora Tomasello, Filippo Caraci, Santina Chiechio, Ferdinando Nicoletti, Agata Copani

Research output: Contribution to journalArticle

Abstract

Alzheimer's disease is the most common form of dementia among older people and is still untreatable. While β-amyloid protein is recognized as the disease determinant with a pivotal role in inducing neuronal loss and dementia, an impaired brain insulin signaling seems to account in part for the cognitive deficit associated with the disease. The origin of this defective signaling is uncertain. Accumulating toxic species of β-amyloid, the so-called oligomers, has been proposed to be responsible for downregulation of neuronal insulin receptors. We have found that the nontoxic form of β-amyloid, the monomer, is able to activate insulin/insulin-like growth factor-1 (IGF-1) receptor signaling and thus behaves as a neuroprotectant agent. Our suggestion is that depletion of β-amyloid monomers, occurring in the preclinical phase of Alzheimer's disease, might be the cause of early insulin/IGF-1 signaling disturbances that anticipate cognitive decline.

Original languageEnglish
Pages (from-to)605-613
Number of pages9
JournalMolecular Neurobiology
Volume46
Issue number3
DOIs
Publication statusPublished - 2012

Fingerprint

Somatomedins
Amyloid
Alzheimer Disease
Insulin
Dementia
Somatomedin Receptors
Amyloidogenic Proteins
Poisons
Insulin Receptor
Neuroprotective Agents
Down-Regulation
Brain

Keywords

  • β-Amyloid
  • Alzheimer's disease
  • Insulin
  • Insulin-like growth factor 1

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience

Cite this

Beta-Amyloid monomer and insulin/IGF-1 signaling in Alzheimer's disease. / Giuffrida, Maria Laura; Tomasello, Flora; Caraci, Filippo; Chiechio, Santina; Nicoletti, Ferdinando; Copani, Agata.

In: Molecular Neurobiology, Vol. 46, No. 3, 2012, p. 605-613.

Research output: Contribution to journalArticle

Giuffrida, Maria Laura ; Tomasello, Flora ; Caraci, Filippo ; Chiechio, Santina ; Nicoletti, Ferdinando ; Copani, Agata. / Beta-Amyloid monomer and insulin/IGF-1 signaling in Alzheimer's disease. In: Molecular Neurobiology. 2012 ; Vol. 46, No. 3. pp. 605-613.
@article{d4768c7f1ceb4cd192482b4be1415373,
title = "Beta-Amyloid monomer and insulin/IGF-1 signaling in Alzheimer's disease",
abstract = "Alzheimer's disease is the most common form of dementia among older people and is still untreatable. While β-amyloid protein is recognized as the disease determinant with a pivotal role in inducing neuronal loss and dementia, an impaired brain insulin signaling seems to account in part for the cognitive deficit associated with the disease. The origin of this defective signaling is uncertain. Accumulating toxic species of β-amyloid, the so-called oligomers, has been proposed to be responsible for downregulation of neuronal insulin receptors. We have found that the nontoxic form of β-amyloid, the monomer, is able to activate insulin/insulin-like growth factor-1 (IGF-1) receptor signaling and thus behaves as a neuroprotectant agent. Our suggestion is that depletion of β-amyloid monomers, occurring in the preclinical phase of Alzheimer's disease, might be the cause of early insulin/IGF-1 signaling disturbances that anticipate cognitive decline.",
keywords = "β-Amyloid, Alzheimer's disease, Insulin, Insulin-like growth factor 1",
author = "Giuffrida, {Maria Laura} and Flora Tomasello and Filippo Caraci and Santina Chiechio and Ferdinando Nicoletti and Agata Copani",
year = "2012",
doi = "10.1007/s12035-012-8313-6",
language = "English",
volume = "46",
pages = "605--613",
journal = "Molecular Neurobiology",
issn = "0893-7648",
publisher = "Humana Press Inc.",
number = "3",

}

TY - JOUR

T1 - Beta-Amyloid monomer and insulin/IGF-1 signaling in Alzheimer's disease

AU - Giuffrida, Maria Laura

AU - Tomasello, Flora

AU - Caraci, Filippo

AU - Chiechio, Santina

AU - Nicoletti, Ferdinando

AU - Copani, Agata

PY - 2012

Y1 - 2012

N2 - Alzheimer's disease is the most common form of dementia among older people and is still untreatable. While β-amyloid protein is recognized as the disease determinant with a pivotal role in inducing neuronal loss and dementia, an impaired brain insulin signaling seems to account in part for the cognitive deficit associated with the disease. The origin of this defective signaling is uncertain. Accumulating toxic species of β-amyloid, the so-called oligomers, has been proposed to be responsible for downregulation of neuronal insulin receptors. We have found that the nontoxic form of β-amyloid, the monomer, is able to activate insulin/insulin-like growth factor-1 (IGF-1) receptor signaling and thus behaves as a neuroprotectant agent. Our suggestion is that depletion of β-amyloid monomers, occurring in the preclinical phase of Alzheimer's disease, might be the cause of early insulin/IGF-1 signaling disturbances that anticipate cognitive decline.

AB - Alzheimer's disease is the most common form of dementia among older people and is still untreatable. While β-amyloid protein is recognized as the disease determinant with a pivotal role in inducing neuronal loss and dementia, an impaired brain insulin signaling seems to account in part for the cognitive deficit associated with the disease. The origin of this defective signaling is uncertain. Accumulating toxic species of β-amyloid, the so-called oligomers, has been proposed to be responsible for downregulation of neuronal insulin receptors. We have found that the nontoxic form of β-amyloid, the monomer, is able to activate insulin/insulin-like growth factor-1 (IGF-1) receptor signaling and thus behaves as a neuroprotectant agent. Our suggestion is that depletion of β-amyloid monomers, occurring in the preclinical phase of Alzheimer's disease, might be the cause of early insulin/IGF-1 signaling disturbances that anticipate cognitive decline.

KW - β-Amyloid

KW - Alzheimer's disease

KW - Insulin

KW - Insulin-like growth factor 1

UR - http://www.scopus.com/inward/record.url?scp=84880726942&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880726942&partnerID=8YFLogxK

U2 - 10.1007/s12035-012-8313-6

DO - 10.1007/s12035-012-8313-6

M3 - Article

C2 - 22886436

AN - SCOPUS:84880726942

VL - 46

SP - 605

EP - 613

JO - Molecular Neurobiology

JF - Molecular Neurobiology

SN - 0893-7648

IS - 3

ER -